Stay updated on Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial page.

Latest updates to the Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed descriptions of a phase II trial involving nivolumab and metformin for treating refractory metastatic colorectal cancer, while adding new identifiers and collaborators related to the study.SummaryDifference54%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check36 days agoNo Change Detected
- Check72 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial page.